Address	Karolinska Institutet Science Park Solna AB 171 48 Sweden
Employees	-
Website	http://www.kancera.com
Updated	09/14/2018
Kancera AB engages in the research, development, and sale of drug candidate to pharmaceutical companies. Its portfolio includes Fractalkine, ROR inhibitors, HDAC6, and PFKFB3 projects. The company was founded by Hakan Mellstedt on April 28, 2010 and is headquartered in Solna, Sweden.